[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-433752-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-433752-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","endovascular-treatment-of-patients-concurrent-with-type-3a-aortic-syndrome-and-degeneration-infrarenal-abdominal-aortic-aneurysm","Endovascular treatment of patients concurrent with type 3A aortic syndrome and degeneration (infrarenal) abdominal aortic aneurysm","","Endovascular treatment has improved outcomes for aortic pathologies, yet managing patients who concurrently have acute DeBakey type 3A aortic syndrome and degenerative infrarenal abdominal aortic aneurysm (AAA) remains challenging. This study analyzed 11 patients treated from 2012 to 2019 who met intervention criteria based on acute dissection features, intramural hematoma/penetrating ulcer measurements, and AAA diameter. Outcomes were assessed through the end of 2022, including reinterventions and mortality.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/endovascular-treatment-of-patients-concurrent-with-type-3a-aortic-syndrome-and-degeneration-infrarenal-abdominal-aortic-aneurysm/433752/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/endovascular-treatment-of-patients-concurrent-with-type-3a-aortic-syndrome-and-degeneration-infrarenal-abdominal-aortic-aneurysm/433752.png","ImageObject",300,407,{"name":42,"@type":43},"Hazel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-29",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What patient condition does the study evaluate?","Question",{"text":63,"@type":64},"Patients concurrently diagnosed with acute DeBakey type 3A aortic syndrome and degenerative infrarenal abdominal aortic aneurysm (AAA).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were treatments delivered in one-stage versus two-stage strategies?",{"text":68,"@type":64},"One-stage patients underwent a single operation, while the two-stage strategy used EVAR first and then TEVAR over an interval ranging from 3 to 52 months.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key outcome and safety findings regarding spinal cord ischemia?",{"text":72,"@type":64},"No spinal cord ischemia was observed in either group during follow-up; aortic events requiring reintervention occurred only in the two-stage group.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},433752,1790718472,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","J Chin MedAssoc  \nOriginal article  \nEndovascular treatment of patients concurrent with type 3A aortic syndrome and degeneration (infrarenal) abdominal aortic aneurysm  \nShih-Ying Meia, Chun-Yang Huanga,b, Chun-Che Shihc, Chiao-Po Hsua,b,*  \naDivision of Cardiac Vascular Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC; bSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC; cDivision of Cardiovascular Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, ROC  \nAbstract  \nBackground: Advances in endovascular treatments have improved surgical outcomes for patients with aortic pathologies. However, for patients with comorbid aortic dissection and degenerative abdominal aortic aneurysm (AAA), effective surgical treatment is often a challenge. Here, we analyzed the outcomes of endovascular treatment in patients who concurrently had acute DeBakey type 3A aortic syndrome and degenerative infrarenal AAA.  \nMethods: From 2012 to 2019, 11 patients were diagnosed concurrently with acute type 3A aortic syndrome and degenerative infrarenal AAA that met intervention criteria (typical acute descending aortic dissection, or thickness of hematoma or ulceration greater than 10 mm in intramural hematomas [IMH] or penetrating aortic ulcers [PAU], in addition to AAA diameter >5 cm) . Three patients had a typical dissection, three had IMH, and five had PAU.  \nResults: Four men underwent a one-stage operation, and preoperative cerebrospinal fluid lumbar drainage was instituted in three patients. The other seven patients underwent a two-stage operation consisting of endovascular aneurysm repair (EVAR) followed by thoracic endovascular aortic repair (TEVAR) over a period ranging from 3 to 52 months. Follow-up continued until the end of 2022. No spinal cord ischemia (SCI) was present in either group. In the one-stage group, one patient died of intracranial hemorrhage 1.5 months after the operation. The other three patients did not experience any aortic event requiring reintervention. In the two-stage group, four patients required reintervention, including one type I endoleak, 2 type II endoleaks, and one visceral artery stent compromise. In this group, four patients died during follow-up.  \nConclusion: Mid-term outcomes were acceptable in patients with concurrent acute type 3A aortic syndrome and degenerative infra-renal AAA, managed with EVAR and TEVAR, both simultaneously and sequentially. The incidence of SCI was low, and aortic coverage spared the segment from T8 to L1 .  \nKeywords: Degeneration (infrarenal) aortic aneurysm; Endovascular treatment; Type 3A aortic syndrome  \n964 [www.ejcma.org](www.ejcma.org)  \nOriginal Article. (2025) 88:12 J Chin MedAssoc  \nLay Summary: Operation of treating people who simultaneously develop DeBakey type 3A dissection and infrarenal abdominal aorta aneurysm is tricky and uncommon. This study reviewed 11 such patients at Taipei Veterans General Hospital between 2012 and 2019. Doctors used minimally-invasive stent grafts: some received chest and abdominal repairs in one operation, others in two stages months apart. Over up to 10 years of follow-up, no patient developed paralysis from spinal cord ischemia. Oneof four one-stage patients died early from a brain bleed and four of seven two-stage patients later died from other diseases, while only the two-stage group needed reoperations to fix small leaks or a blocked stent. Overall, both approaches looked safe and effective.  \n1. INTRODUCTION  \nAortic dissection and aneurysm are major pathological conditions that share risk factors such as systemic hypertension and atherosclerosis.1 Because aortic dissection and aneurysm are fairly prevalent conditions, one can reasonably assume that they can occur concurrently in the same patient. Hence, patients may frequently be diagnosed with a mild abdominal aortic dilation (aneurysmal change) or ascending aortic dilation in ad","cbCaipDcwiH96BVv","https://ap.wps.com/l/cbCaipDcwiH96BVv","pdf",813020,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What patient condition does the study evaluate?\",\"answer\":\"Patients concurrently diagnosed with acute DeBakey type 3A aortic syndrome and degenerative infrarenal abdominal aortic aneurysm (AAA).\"},{\"question\":\"How were treatments delivered in one-stage versus two-stage strategies?\",\"answer\":\"One-stage patients underwent a single operation, while the two-stage strategy used EVAR first and then TEVAR over an interval ranging from 3 to 52 months.\"},{\"question\":\"What were the key outcome and safety findings regarding spinal cord ischemia?\",\"answer\":\"No spinal cord ischemia was observed in either group during follow-up; aortic events requiring reintervention occurred only in the two-stage group.\"}]","Endovascular treatment of patients concurrent with type 3A aortic syndrome and degeneration (infrarenal) abdominal aortic aneurysm | PDF",1790665365,18]